Literature DB >> 8284258

Vasoactive intestinal peptide (VIP) causes memory impairment in passive avoidance responding of the rat.

A Takashima1, Y Maeda, S Itoh.   

Abstract

Our previous studies demonstrated that CCK-8 and its analog, cerulein (CER), have a potent preventive action on experimental amnesia, and that VIP has reciprocal action against CCK-8 and CER. Since VIP has been reported to cause amnesia, we carried out the present experiments to confirm this action and to examine the preventive effect of CER on VIP-induced amnesia. In the passive avoidance response, central administration, but not peripheral injection, of VIP caused amnesia; the effective portion of the molecule was found to be located in the N-terminus amino acid sequence. Secretin and PACAP, which have similar molecular structures to that of VIP, had no amnestic action. Preadministration of CER prevented VIP-induced memory deficit. The VIP antagonists did not affect amnesia induced by electroconvulsive shock and scopolamine. It was concluded that CER prevents VIP-induced memory deficit in the passive avoidance response of the rat.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8284258     DOI: 10.1016/0196-9781(93)90088-x

Source DB:  PubMed          Journal:  Peptides        ISSN: 0196-9781            Impact factor:   3.750


  6 in total

1.  VIP alleviates sepsis-induced cognitive dysfunction as the TLR-4/NF-κB signaling pathway is inhibited in the hippocampus of rats.

Authors:  Yujiao Yang; Debo Yun; Biqian Dong; Yuan Geng; Yong Wan
Journal:  J Mol Histol       Date:  2022-03-03       Impact factor: 2.611

2.  Endogenous VIP VPAC1 Receptor Activation Modulates Hippocampal Theta Burst Induced LTP: Transduction Pathways and GABAergic Mechanisms.

Authors:  Ana Caulino-Rocha; Nádia Carolina Rodrigues; Joaquim Alexandre Ribeiro; Diana Cunha-Reis
Journal:  Biology (Basel)       Date:  2022-04-20

Review 3.  VIP Modulation of Hippocampal Synaptic Plasticity: A Role for VIP Receptors as Therapeutic Targets in Cognitive Decline and Mesial Temporal Lobe Epilepsy.

Authors:  Diana Cunha-Reis; Ana Caulino-Rocha
Journal:  Front Cell Neurosci       Date:  2020-06-12       Impact factor: 5.505

4.  Vasoactive intestinal polypeptide plasma levels associated with affective symptoms and brain structure and function in healthy females.

Authors:  Rozalyn A Simon; Nawroz Barazanji; Michael P Jones; Olga Bednarska; Adriane Icenhour; Maria Engström; J Paul Hamilton; Åsa V Keita; Susanna Walter
Journal:  Sci Rep       Date:  2021-01-14       Impact factor: 4.379

5.  Select cognitive deficits in vasoactive intestinal peptide deficient mice.

Authors:  Dipesh Chaudhury; Dawn H Loh; Joanna M Dragich; Arkady Hagopian; Christopher S Colwell
Journal:  BMC Neurosci       Date:  2008-07-10       Impact factor: 3.288

Review 6.  The Potential Role of Gut Peptide Hormones in Autism Spectrum Disorder.

Authors:  Xin-Rui Qi; Li Zhang
Journal:  Front Cell Neurosci       Date:  2020-03-31       Impact factor: 5.505

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.